Abstract

Qorvo will report fiscal fourth-quarter results on May 5, 2026 Post Market, with the market bracing for year-over-year revenue contraction but stronger profitability metrics; investors will watch whether cost discipline and favorable mix sustain margin resilience despite softer top-line trends.

Market Forecast

For the fiscal quarter to be reported, current projections indicate Qorvo will deliver revenue of 800.56 million US dollars, a year-over-year decline of 5.86%, while EBIT is projected at 144.61 million US dollars (up 20.99% year over year) and adjusted EPS is estimated at 1.21 (up 20.41% year over year). Gross margin and net margin guidance are not explicitly captured in the current-quarter forecast data, but the combination of revenue decline and growth in EBIT/EPS implies expectations for improved operating leverage and a richer product mix.

The main business remains centered on the Advanced Cellular Group (ACG), which generated 690.76 million US dollars in the prior quarter and will continue to set the tone for quarterly performance given its scale. The most promising incremental growth contributors are the High Performance Analog (HPA) and the Connectivity & Sensors Group (CSG), which posted 190.90 million US dollars and 111.30 million US dollars respectively in the prior quarter and are expected to support profitability through higher-value content and ongoing mix shifts.

Last Quarter Review

In the most recently reported quarter, Qorvo delivered revenue of 993.00 million US dollars (up 8.37% year over year), gross margin of 46.65%, GAAP net profit attributable to the parent company of 164.00 million US dollars, net profit margin of 16.52%, and adjusted EPS of 2.17 (up 34.78% year over year).

A notable highlight was earnings outperformance versus market expectations: adjusted EPS of 2.17 exceeded the prior consensus by 0.32, with operating leverage and cost control cushioning unit-driven volatility. In the business mix, ACG led with 690.76 million US dollars, complemented by HPA at 190.90 million US dollars and CSG at 111.30 million US dollars, underscoring the breadth of revenue drivers that helped sustain margin strength.

Current Quarter Outlook

Advanced Cellular Group

ACG remains Qorvo’s largest revenue engine and, by virtue of its scale, the segment that most directly shapes the quarter’s top-line trajectory. The model-implied guidance points to a mid-single-digit decline in overall revenue year over year for the quarter, and because ACG bears the largest weight in the mix, it is reasonable to expect the group to account for much of that directional movement. The key watch items are the balance between volumes and average selling prices across major programs and whether cost containment measures can preserve margins as shipments normalize from peak seasonal levels. Even without explicit segment-level outlook, the consolidated forecast—lower revenue paired with higher EBIT and EPS—suggests that within ACG, pricing, content mix, and cost discipline remain critical levers, potentially tempering gross margin variability despite softer top-line. Execution on supply chain efficiency and yield, together with effective allocation of production and inventory, will be central to sustaining profit per unit and keeping decremental margins in check as revenue steps down seasonally.

High Performance Analog and Connectivity & Sensors

HPA and CSG together represent smaller revenue bases than ACG but are positioned as key contributors to the expected improvement in profitability metrics this quarter. With last quarter’s revenues of 190.90 million US dollars (HPA) and 111.30 million US dollars (CSG), these franchises help diversify cash flows and can provide margin ballast because of their product economics and less concentrated customer exposure. The company’s current-quarter forecast showing EBIT and EPS growth year over year despite a revenue decline implies an ongoing mix shift into higher-value, more profitable product lines and the early benefits of cost structure refinements. On that basis, HPA and CSG are poised to do disproportionate work for EBIT and EPS resilience, provided that operating expenses remain contained and product ramps continue to track internal schedules. Investors will scrutinize order cadence and backlog conversion across these lines for signals that the profitability uplift is rooted in sustainable product and customer mix rather than purely in temporary cost measures.

Stock Price Swing Factors This Quarter

Two datapoints dominate the near-term playbook: the spread between revenue and profitability trajectories, and ongoing corporate actions that could alter the investment narrative. The forecast profile—down 5.86% year-over-year revenue against double-digit year-over-year growth in EBIT and EPS—creates a test for the durability of margin management; any deviation on gross margin or opex discipline would quickly translate into EPS volatility given the leaner top line. Conversely, confirmation that mix and cost actions are sustainable would support multiple stabilization even with subdued sales.

Another swing factor is the regulatory path for the proposed combination with Skyworks Solutions. In early February 2026, the companies received a request for additional information from the U.S. Federal Trade Commission, extending the review period. While this process does not directly affect current-quarter revenue recognition, it can influence equity risk premia by introducing timeline uncertainty around potential cost synergies and strategic optionality. Investors will therefore parse management’s commentary for incremental details on regulatory progress, anticipated integration milestones, and any interim steps to align product portfolios in case of an extended review.

Finally, quarterly performance will likely hinge on how well Qorvo calibrates inventory and production to demand signals across programs. With the consolidated forecast implying margin resilience, markets will look for confirmations in gross margin cadence, operating expense control, and conversion of earnings to cash. Any update on share repurchases, capital allocation priorities, and spending tied to future product introductions can also shape sentiment by signaling the company’s conviction in sustaining the current profitability trajectory despite near-term top-line softness.

Analyst Opinions

Based on items published between January 1, 2026 and April 28, 2026, the balance of commentary skews cautious: bearish-to-cautious views outnumber bullish ones by roughly 2 to 1. In March 2026, TD Cowen maintained a Hold rating and reduced its price target to 80 US dollars, framing improving profitability as counterbalanced by a weak long-term revenue outlook. Around the same period, Mizuho Securities reiterated a Hold rating with a 70 US dollars target, signaling guarded expectations for the revenue recovery path and a preference to see greater visibility before upgrading. These viewpoints coalesce around a common theme: supportive margin execution is evident, yet uncertainty on top-line acceleration keeps the risk-reward balanced-to-capped near term.

The cautious camp’s analytical case centers on three points. First, the current-quarter revenue forecast of 800.56 million US dollars, down 5.86% year over year, validates that the near-term sales trajectory is still consolidating. Second, the guidance-equivalent model indicates EBIT and EPS can grow year over year, which is positive, but analysts emphasize that sustaining this spread requires continued mix benefits and tight expense control—variables that could be sensitive to demand shifts across large programs. Third, while corporate actions introduce potential strategic upside over time, the regulatory review cycle and integration prerequisites inject an element of timing ambiguity. Within this framing, the modal recommendation has been to await clearer evidence of revenue inflection before shifting stance, even as analysts acknowledge the tangible progress on profitability.

For investors gauging this quarter, the cautious perspective translates into clear checkpoints. Revenue arriving close to the 800.56 million US dollars forecast would be consistent with a controlled normalization scenario; materially better sales could catalyze a reassessment of growth durability. On profitability, evidence that gross margin remains near recent levels and that EBIT reaches the 144.61 million US dollars neighborhood would reinforce the premise that HPA and CSG mix gains and operational efficiencies are doing the heavy lifting. Lastly, any incremental clarity regarding regulatory milestones and the associated synergy timeline could influence how quickly the Street credits future EPS accretion. In sum, while one high-profile upgrade in April 2026 underscores that upside scenarios are plausible, the majority view within the latest window remains guarded—supportive of margin work but reserving judgment on the speed and magnitude of a top-line reacceleration.